The 6 analysts offering 12-month price forecasts for Twist Bioscience Corp have a median target of 111.50, with a high estimate of 130.00 and a low estimate of 85.00. The median estimate represents a +110.70% increase from the last price of 52.92.
The current consensus among 8 polled investment analysts is to Buy stock in Twist Bioscience Corp. This rating has held steady since September, when it was upgraded from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.06
Reporting Date Feb 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.